FDA
approval
· 2019-09-12
FDA Approved: IBSRELA — Original Application (Ardelyx, Inc.)
Summary
The FDA approved IBSRELA (tenapanor hydrochloride) in an original NDA for the treatment of irritable bowel syndrome with constipation. This marks the introducti…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for IBSRELA (TENAPANOR HYDROCHLORIDE)